Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Diabetic Nephropathies / pathology"'
Autor:
Christoffersen, Berit Østergaard, Kristensen, Camilla Aarup, Lindgaard, Rikke, Kirk, Rikke Kaae, Viuff, Birgitte Martine, Kvist, Peter Helding, Pedersen, Henrik Duelund, Ludvigsen, Trine Pagh, Skovgaard, Tine, Fels, Johannes Josef, Martinussen, Torben, Christiansen, Liselotte Bruun, Cirera, Susanna, Olsen, Lisbeth Høier
Publikováno v:
Christoffersen, B Ø, Kristensen, C A, Lindgaard, R, Kirk, R K, Viuff, B M, Kvist, P H, Pedersen, H D, Ludvigsen, T P, Skovgaard, T, Fels, J J, Martinussen, T, Christiansen, L B, Cirera, S & Olsen, L H 2023, ' Functional and morphological renal changes in a Göttingen Minipig model of obesity-related and diabetic nephropathy ', Scientific Reports, vol. 13, 6017 . https://doi.org/10.1038/s41598-023-32674-6
Obesity-related glomerulopathy and diabetic nephropathy (DN) are serious complications to metabolic syndrome and diabetes. The purpose was to study effects of a fat, fructose and cholesterol-rich (FFC) diet with and without salt in order to induce hy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9446f97cb45623a5b840fed07f9251e
https://doi.org/10.1038/s41598-023-32674-6
https://doi.org/10.1038/s41598-023-32674-6
Autor:
Jakob A. Østergaard, Jay C. Jha, Arpeeta Sharma, Aozhi Dai, Judy S.Y. Choi, Judy B. de Haan, Mark E. Cooper, Karin Jandeleit-Dahm
Publikováno v:
Østergaard, J A, Jha, J C, Sharma, A, Dai, A, Choi, J S Y, De Haan, J B, Cooper, M E & Jandeleit-Dah, K 2022, ' Adverse renal effects of NLRP3 inflammasome inhibition by MCC950 in an interventional model of diabetic kidney disease ', Clinical Science, vol. 136, no. 2, pp. 167-180 . https://doi.org/10.1042/CS20210865
Clinical Science (London, England : 1979)
Clinical Science (London, England : 1979)
Activation of nucleotide-binding oligomerization domain-like receptor pyrin domain containing 3 (NLRP3) inflammasome has been reported in diabetic complications including diabetic kidney disease (DKD). However, it remains unknown if NLRP3 inhibition
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ecb74c1c6696820a6519eb2f38a2726e
https://doi.org/10.1042/cs20210865
https://doi.org/10.1042/cs20210865
Autor:
Pedro Vieira, Flávio Reis, Sofia D. Viana, Sara Nunes, Inês Preguiça, Fernando Mendes, Adelaide Barbosa, André Alves, Diana Raquel Fernandes Martins
Publikováno v:
Nutrients, Vol 12, Iss 4, p 881 (2020)
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Agência para a Sociedade do Conhecimento (UMIC)-FCT-Sociedade da Informação
instacron:RCAAP
Nutrients
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Agência para a Sociedade do Conhecimento (UMIC)-FCT-Sociedade da Informação
instacron:RCAAP
Nutrients
Diabetic nephropathy (DN) is a major microvascular complication of diabetes. Obesity and hyperlipidemia, fueled by unhealthy food habits, are risk factors to glomerular filtration rate (GFR) decline and DN progression. Several studies recommend that
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::589f17502d2721c822726c59205ab205
https://www.mdpi.com/2072-6643/12/4/881
https://www.mdpi.com/2072-6643/12/4/881
Autor:
Cira Di Gioia, Raffaella Carletti, Silvia Maestroni, Thomas Unger, Giovanna Castoldi, C. Bombardi, Andrea Stella, Gianpaolo Zerbini, U. Muscha Steckelings, Björn Dahlöf
Publikováno v:
Castoldi, G, di Gioia, C R, Bombardi, C, Maestroni, S, Carletti, R, Steckelings, U M, Dahlöf, B, Unger, T, Zerbini, G & Stella, A 2014, ' Prevention of diabetic nephropathy by compound 21, selective agonist of angiotensin type 2 receptors, in Zucker diabetic fatty rats ', American Journal of Physiology: Renal Physiology, vol. 307, no. 10, pp. F1123-F1131 . https://doi.org/10.1152/ajprenal.00247.2014
American Journal of Physiology-Renal Physiology, 307(10), F1123-F1131. American Physiological Society
American Journal of Physiology-Renal Physiology, 307(10), F1123-F1131. American Physiological Society
The aim of this study was to evaluate the effect of compound 21 (C21), a selective AT2 receptor agonist, on diabetic nephropathy and the potential additive effect of C21, when associated with losartan treatment, on the development of albuminuria and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ae3004315f2ff815d8cad4b294592e2
https://doi.org/10.1152/ajprenal.00247.2014
https://doi.org/10.1152/ajprenal.00247.2014
Autor:
C. Garbarsch, Torsten Deckert, Jhm Berden, Pernille M. Hansen, Hiroki Yokoyama, P.E. Hoyer, J. van den Born, Tonny Jensen
Publikováno v:
Diabetes, 46, pp. 1875-1880
Diabetes, 46, 1875-1880
Diabetes, 46, 11, pp. 1875-1880
Diabetes, 46(11), 1875-1880. AMER DIABETES ASSOC
Diabetes, 46, 1875-1880
Diabetes, 46, 11, pp. 1875-1880
Diabetes, 46(11), 1875-1880. AMER DIABETES ASSOC
In IDDM patients, an increased permeability of the glomerular capillaries has been associated with a general loss of negatively charged heparan sulfate proteoglycans (HSPGs) within basement membranes (BMs). In the present study, we used immunohistoch
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::588c5b844a632b87e256c4effd52cf19
https://hdl.handle.net/2066/222734
https://hdl.handle.net/2066/222734
